Trexquant Investment LP purchased a new position in shares of UiPath Inc. (NYSE:PATH - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 1,228,274 shares of the company's stock, valued at approximately $15,611,000. Trexquant Investment LP owned about 0.22% of UiPath at the end of the most recent quarter.
Several other large investors have also recently modified their holdings of PATH. CIBC Asset Management Inc lifted its holdings in UiPath by 5.3% during the 4th quarter. CIBC Asset Management Inc now owns 14,741 shares of the company's stock worth $187,000 after purchasing an additional 736 shares in the last quarter. V Square Quantitative Management LLC raised its stake in shares of UiPath by 33.4% during the fourth quarter. V Square Quantitative Management LLC now owns 3,030 shares of the company's stock worth $39,000 after acquiring an additional 759 shares in the last quarter. First Horizon Advisors Inc. lifted its stake in UiPath by 47.8% in the fourth quarter. First Horizon Advisors Inc. now owns 2,487 shares of the company's stock worth $32,000 after purchasing an additional 804 shares during the last quarter. Amalgamated Bank grew its position in UiPath by 3.1% during the 4th quarter. Amalgamated Bank now owns 28,148 shares of the company's stock worth $358,000 after acquiring an additional 836 shares during the last quarter. Finally, Smartleaf Asset Management LLC raised its holdings in UiPath by 88.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 2,454 shares of the company's stock valued at $31,000 after buying an additional 1,152 shares during the last quarter. Institutional investors own 62.50% of the company's stock.
UiPath Trading Down 2.2 %
NYSE:PATH traded down $0.23 on Friday, hitting $10.04. 21,037,997 shares of the stock were exchanged, compared to its average volume of 9,970,369. The stock has a market cap of $5.53 billion, a PE ratio of -62.72 and a beta of 1.04. The stock has a fifty day moving average of $12.58 and a 200-day moving average of $12.97. UiPath Inc. has a fifty-two week low of $9.50 and a fifty-two week high of $21.90.
Analysts Set New Price Targets
A number of equities analysts have issued reports on the company. Scotiabank decreased their price objective on UiPath from $15.00 to $12.00 and set a "sector perform" rating for the company in a report on Thursday, March 13th. Needham & Company LLC reissued a "hold" rating on shares of UiPath in a report on Wednesday, March 26th. Wells Fargo & Company dropped their price objective on shares of UiPath from $13.00 to $11.00 and set an "equal weight" rating on the stock in a report on Thursday, March 13th. BMO Capital Markets reduced their target price on shares of UiPath from $16.00 to $11.50 and set a "market perform" rating for the company in a report on Friday, March 14th. Finally, Mizuho dropped their price objective on UiPath from $14.00 to $12.00 and set a "neutral" rating for the company in a research note on Thursday, March 13th. Two analysts have rated the stock with a sell rating, fifteen have given a hold rating and two have given a buy rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $13.62.
View Our Latest Report on UiPath
UiPath Profile
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Recommended Stories

Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.